Article information
Full text is only aviable in PDF
Bibliografía
[1.]
S.D.L. Lebowitz, B. Burrows.
Epidemiology of chronic obstructive pulmonary disease.
Clin Chest Med, 11 (1990), pp. 374-387
[2.]
B.G. Ferris, I.T. Higgins, M.W. Higgins, et al.
Chronic nonspecific respiratory disease.
Berlín, New Hampshire 1961-1967: A crosssectional study. Am Rev Respir Dis, 104 (1971), pp. 232
[3.]
I.B. Targer, M. Segal, F.E. Speizer, S.T. Weiss.
The natural history of forced expiratory voluntes.
Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis, 138 (1988), pp. 837
[4.]
P.J. Barnes, S. Pedersen.
Efficacy and safety of inhaled corticosteroids in asthma.
Am Rev Respir Dis, 148 (1993), pp. 51-526
[5.]
R. Djukanovic, J.W. Wilson, K.M. Britten, S.J. Wilson, A.F. Walls, W.R. Roche, et al.
Effect of inhaled corticosteroids on airway inflammation and symptoms in asthma.
Am Rev Respir Dis, 145 (1992), pp. 669-674
[6.]
C. Burke, C.K. Power, A. Norris, A. Condez, B. Schmekel, L.W. Poulter.
Lung function and immunopathological changes after inhaled corticosteroids therapy in asthma.
Eur Respir J, 5 (1992), pp. 73-79
[7.]
S.L. Ollerenshaw, A.J. Woolcock.
Characteristics of the inflammation in biopsies from large airways of subjects, with asthma and subjects with chronic airflow limitation.
Am Rev Respir Dis, 145 (1992), pp. 922-927
[8.]
M. Cosio, H. Gezzo, J.C. Hogg, et al.
The relation between structural changes in small airways and pulmonarv function test.
N Engl J Med, 298 (1977), pp. 1.277-1.281
[9.]
R.A. Pauwels, C.-G. Lofdahl, N.B. Pride, D.S. Postma, L.A. Laitinen, S.V. Ohlsson.
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design.
Eur Respir J, 5 (1992), pp. 1.254-1.261
[10.]
R.K. Albert, T.R. Martin, S.W. Lewis.
Controlled clinical trial of methylprednisolone in patients with bronchitis and acute respiratory insuficiency.
Ann Intern Med, 92 (1980), pp. 753-758
[11.]
R.W. Glenny.
Steroids in COPD, the scripture according to Albert [carta], Chest, 91 (1987), pp. 289-290
[12.]
O. Eliasson, J. Hoffman, D. Trueb, et al.
Steroids in COPD, the scripture accordint to Albert [carta], Chest.
, 91 (1987), pp. 290
[13.]
C.L. Emerman, A.F. Connors, T.W. Lukens, et al.
A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD.
Chest, 95 (1989), pp. 563-567
[14.]
G.H. Murata, M.S. Gorby, T.W. Chick, et al.
Intravenous and oral corticosteroids for the prevention of relapse after treatment of descompesated COPD.
Effect on patients with a history of multiples relapses. Chest, 98 (1990), pp. 845-849
[15.]
D.M. Mitchell, P. Gilden, A.H. Dimond, J. Collins.
V. Value of serial peak expiratory flow measurements in assessing treatment responso in chronic airflow limitation.
Thorax, 41 (1986), pp. 606-610
[16.]
A.S. Robertson, R.I. Gove, G.A. Wieland, P.S. Burge.
A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1500 pg/day in patients with adult onset chronic obstructive airways disease.
Eur J Respir Dis, 146 (1986), pp. 565-569
[17.]
F.J. Fuleihan, K.A. Feisal, N.N. Malouf.
Effect of corticosteroids on pulmonary function in chronic bronchitis with airway obstruction.
Am Rev Respir Dis, 96 (1967), pp. 678-684
[18.]
S.M. Harding, S. Freedman.
A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.
Thorax, 33 (1978), pp. 214-218
[19.]
T.C. Stokes, J.M. Shaylor, J.F. O’Relly, B.D. Harrison.
Assessment of sleroid responsivcness in patients with chronic airflow obstruction.
Lancet, 2 (1982), pp. 345-348
[20.]
D.M. Mitchell, P. Gildeh, M. Relahn, A.H. Dimond.
Effects of prednisolone in chronic airflow limitation.
Lancet, 2 (1984), pp. 193-196
[21.]
W.K. Lam, S.Y. So, D.Y. Yu.
Response to oral corticosteroids in chronic airflow obstruction.
Br J Dis Chest, 77 (1983), pp. 189-198
[22.]
J.F. O’Reillv, J.M. Shaylor, K.M. Fromings, D.W. Harrison.
The use.of the 12 minutes walking test in assessing the effect of oral steroid therapy in patients with chronic airwavs obstruction.
Br J Dis Chest, 76 (1982), pp. 374-382
[23.]
D.S. Strain, G.T. Kinasewitz, D.P. Franco, R.B. George.
Effect of steroid therapy on exercise perfomance in patients with irreversible chronic obstructive pulmonary disease.
Chest, 88 (1985), pp. 718-721
[24.]
F.R. Becrel, J.W. Vanee.
Prednisone treatment for stable pulmonary cmphysema.
Am Rev Respir Dis, 104 (1971), pp. 264-266
[25.]
G.P. Blair, R.W. Light.
Treatment of chronic obstructive pulmonary disease with corticoids.
Chest, 86 (1984), pp. 524-528
[26.]
O. Eliasson, J. Hoffman, D. Trueb, D. Frederick, J.R. McCormick.
Corticosteroids in chronic obstructivo pulmonary disease. A clinical trial and reassesment of the literature.
Chest, 89 (1986), pp. 484-490
[27.]
J.K. Stoller.
Systemic Corticosteroids in stable chronic obstructive pulmonary disease.
Do they work?. [editorial]. Chest, 91 (1987), pp. 155
[28.]
K.A. L’Abbe, A.S. Detsky, Y. O’Rourke.
Meta-analysis in clinical research.
Ann Intern Med, 107 (1987), pp. 224-233
[29.]
C. Callahan, R. Dittus, B. Katz.
Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis.
Ann Intern Med, 114 (1991), pp. 216-223
[30.]
C. Shim, D.E. Stover, M.H. Williams.
Response to corticosteroids in chronic bronchitis.
J Allergy Clin Immunol, 62 (1978), pp. 363-367
[31.]
L.A. Mendella, J. Manfreda, P.W. Warren, N.R. Anthonisen.
Steroid response in stable chronic obstructive pulmonary disease.
Ann Intern Med, 96 (1982), pp. 17-21
[32.]
B.J. Freedman.
Bronchodilators and corticosteroids in chronic bronchitis and emphysema.
Br Med J, (1963), pp. 1.509-1.512
[33.]
D.C. Weir, A.S. Robertson, R.I. Gove, P.S. Burge.
Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.
Thorax, 45 (1990), pp. 118-121
[34.]
D.S. Postma, Steenhuis ÉJ, T.H. Van Der Weeke, H.J. Sluiter.
Severc chronic airflow obstruction: can corticosteroids slow down progression?.
Eur J Respir Dis, 67 (1985), pp. 56-64
[35.]
D.S. Postma, I. Peters, E.J. Steenhuis, H.J. Sluiter.
Moderately severe chronic obstruction.
Can corticosteroids slow down obstruction?. Eur Respir J, I (1988), pp. 22-26
[36.]
D.S. Postma, H. Sluiter.
Prognosis of chronic obstructive pulmonary disease: The dutch experience.
Am Rev Respir Dis, 140 (1989), pp. 100-105
[37.]
L.D. Hudson, C.M. Monti.
Rationale and use corticosteroids in. chronic obstructive pulmonary disease.
Med Clin North Am, 74 (1990), pp. 661-690
[38.]
I. Zimmet.
Pharmacologic therapy of obstructive airway disease.
Clin Chest Med, 11 (1990), pp. 471-472
[39.]
S.W. Clarke.
Chronic bronchitis in the 1990s: Up-to-date treatment.
Respiration, 58 (1991), pp. 43-46
[40.]
M. Nisar, M. Walshaw, J.E. Earis, M.G. Pearson, P.M.A. Calverly.
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Thorax, 45 (1990), pp. 190-194
[41.]
H.A.M. Kerstjens, P.L.P. Brand, P.H. Quanjer, B.H.H.A. Van der Bruggenbogaarts, G.H. Koëter, D.S. Postma.
Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airway disease.
Thorax, 48 (1993), pp. 722-729
[42.]
D.C. Weir, R.L. Gove, A.S. Robertson, P.S. Burge.
Response to. corticosteroids in chronic airflow obstruction: relationship to emphvsema and airways collapse.
Eur Respir J, 4 (1991), pp. 1.185-1.190
[43.]
M. Nisar, J.E. Earis, M.G. Pearson, P.M.A. Calverley.
Acute bronchodilator trials in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 146 (1992), pp. 555-559
[44.]
G. Guyatt, D. Sackett, D.W. Taylor, J. Chong, R. Roberts, S. Pugsley.
Determining optimal therapy -randomized triáis in individuals patients.
N Eng J Med, 314 (1986), pp. 889-892
[45.]
R. Gilbcrt.
Corticosteroids for chronic obstructive pulmonary disease [carta].
Ann Intern Med, 114 (1991), pp. 704
[46.]
E.F. Juniper, P.A. Kline, A. Vanzieleghem, E.H. Ramsdale, P.M. O’Byrne, F.E. Hargreave.
Effect of long term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non steroid-dependent asthmatics.
Am Rev Respir Dis, 142 (1990), pp. 832-836
[47.]
B. Auffart, D.S. Postma, J.G.R. Monchy, Van der Mark ThW, M. Boorsma, G.H. Koëter.
Effects of inhaled budesonide on spiromctric values, reversibility. airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.
Thorax, 46 (1991), pp. 372-377
[48.]
D.C. Weir, R.I. Gove, A.S. Robertson, P.S. Burge.
Corticosteroid triáis in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomcthasone dipropionate.
Thorax, 45 (1990), pp. 112-117
[49.]
Wardman Ag, F.G. Simpson, A.J. Knox, R.L. Page, J. Cooke.
The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways discase.
Br J Dis Chest, 82 (1988), pp. 168-171
[50.]
A.B. Thompson, M.B. Mueller, A.J. Heires, T.L. Bohling, D. Daughton, S.W. Yancey, et al.
Aerosolized beclomethasone in chronic bronchitis.
Improved pulmonary function and disminished airway inflammation. Am Rev Respir Dis, 146 (1992), pp. 389-395
[51.]
T. Engel, J.H. Heining, O. Madsen, M. Hansen, E.R. Weeke.
A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis.
Eur Respir J, 2 (1989), pp. 935-939
[52.]
A. Watson, T. Keang Lim, H. Joyce, N.B. Pride.
Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction.
Chest, 101 (1992), pp. 350-355
[53.]
D.C. Weir, P.S. Burge.
Effects of high dose inhaled beclomethasone dipropionate, 750 pg and 1500 pg twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
Thorax, 48 (1993), pp. 309-316
[54.]
E. Dompeling, C.P. Van Schayck, P.M. Van Grunsven, C.L.A. Van Herwaarden, R. Akkermans, J. Molema, et al.
Slowing the. deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
Ann Intern Med, 118 (1993), pp. 770-778
[55.]
Kerstjens HAM, Brand PLP, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease.
[56.]
J.A. Wedzicha.
Inhaled corticosteroids in COPD: awaiting controlled trials [editorial].
Thorax, 48 (1993), pp. 305-307
[58.]
N.J. Gross.
Chronic obstructive pulmonary disease.
Current concepts and therapeutic approaches. Chest, 97 (1990), pp. 195-235
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
